Clinical Trials Offered by Breathe Clear Institute

Being Part of a Clinical Trial at Breathe Clear 

What is a clinical trial? A clinical trial is a type of research study that helps determine how effective new medications, treatments, and devices are for patients. The information gathered from the study adds to medical knowledge, indicating what will and won’t work when it comes to treating various diseases and conditions. There are many personal benefits when it comes to being part of a clinical trial. Individuals are able to experience a high standard of care from some of the best qualified medical professionals and access innovative treatments that are not available to the public. The Breathe Clear Institute is proud to offer several clinical trials, including those which treat chronic sinusitis, stable sensorineural hearing loss, and chronic non-allergic or allergic rhinitis. We at Breathe Clear want to improve the health of current and future generations, which is why we are offering these trials to those who have experienced symptoms associated with these conditions. Learn more about the qualifications of our clinical trials below. 

Chronic Sinusitis

Chronic sinusitis occurs when a person’s sinuses are inflamed and infected for three months or more. In order to qualify for this clinical trial, the potential participant must be at least 18 years or older. The participant must have experienced two of the following symptoms over a 12 week period or more: congestion, nasal discharge, facial pain and pressure in the sinus region, and loss or reduction in sense of smell. 

Stable Sensorineural Hearing Loss

Stable sensorineural hearing loss occurs as a result of loss of or damaged hair cells in the cochlea, which is part of the inner ear. This study will be conducted with FX-322 and potential participants must be between the ages of 18-65 and have an already established diagnosis of  stable sensorineural hearing loss by standard hearing tests. 

Chronic Non-Allergic or Allergic Rhinitis 

Rhinitis occurs when the mucous membrane of the nose is inflamed. This clinical study is with ClariFix, and potential participants must be at least 21 years or older, have a diagnosis of chronic non-allergic or allergic rhinitis, and experience moderate to severe symptoms of rhinorrhea and mild to severe symptoms of nasal congestion.

Contact Us Today

If you believe you or someone you know would qualify for one of our clinical trials, contact Breathe Clear Institute today. It is our mission to bring clinical research to as many lives as possible, all while delivering compassionate, respectful, and exceptional care.

Contact Us